Another Breakthrough for “Dry Eye" - Global and China trend . Are you ready?

• Epidemiology of dry eye indication globally and in China
• Treatment of dry eye global and China
• Global top sales of dry eye products and pipeline compare to China
• Global and China ophthalmology speticialty pharma at a glance
• Lingmed Asset Recommendation

Event details

Agenda

• 16:00 - 16:10 Linkedbio services & projects introductions    by LingLing Cao
• 16:10 - 16.45 Another Breakthrough for “Dry Eye" - Global and China trend    by Hank Wang
• 16:45 - 16:55 Panel discussions
• 16:55 - 17:00 Q&A

Presenters

Lingling Cao CEO & Founder Lingling has more than a decade of experience in the healthcare industry, especially in deal-making. She founded Lingmed, which aims to support BD professionals to make better decisions with intelligence databases and EU-China cross-border deals. Prior to her venture at Lingmed, she was a senior BD manager for Eli Lilly in Shanghai and a consultant for McKinsey in Germany

Hank Wang Medical advisor Dr Wang holds a PhD degree on Medicinal Chemistry from Peking University, has a Postdoc experience in University of Missouri-Saint Louis, and worked as a Postdoc Fellow in Auburn University. Hank Wang has more than 10 years’ experience in pharmaceuticals industry. Hank has worked as Vice President and President of R&D at Beijing Haiyan Pharmaceutical Co., Ltd. - Yangtze River Pharmaceutical Group. Dr Wang advises Lingmed on innovative assets evaluation for China market